Today, the population of people aged 60 years or above is growing much faster than it was a few years back. As per the World Health Organization (WHO), the proportion of aged people will nearly double from 12% in 2015 to 22% in 2050. Owing to this, the medical settings need to be prepared for catering to the needs of this age group, since the geriatric population is more susceptible to diseases and therefore requires frequent and effective care. As a person grows older, their bodily functions start needing much more care. The physical body becomes weaker, which is why older people are also more prone to muscle spasms and body pain.
Out of these, the demand for facial aesthetic relaxants was the highest in the past, which is basically because of the high safety and efficiency of these drugs. Different types of facial aesthetic relaxant drugs are dysport and Botox, between which, the demand for Botox was higher in the past. Other than this, the demand for skeletal muscle relaxants is also expected to rise in the near future. Antispastic and antispasmodic are two types of skeletal muscle relaxants. Antispastic agents are utilized for conditions such as multiple sclerosis and cerebral palsy and antispasmodic agents are used for the management of musculoskeletal conditions such as neck pain, tension headaches, and lower back pain.
The growing incidence of skin diseases is also resulting in the growing requirement for different muscle relaxant drugs. Factors such as exposure to ultraviolet radiation, excessive tobacco and alcohol consumption, and surging pollution lead to reduction in reduced skin elasticity and the skin becomes susceptible to sunburns. In addition to this, acne is the most common dermatological condition and affects a large number of people all across the globe. Attributed to these factors, people are increasingly making use of botulinum toxic-based muscle relaxant procedures for treating skin diseases.
Owing to the growing utilization of facial muscle relaxants and surging geriatric population, North America has been a major consumer of muscle relaxants in the past. Furthermore, increasing research & development investments, rising awareness regarding musculoskeletal problems and their management, and advancements in healthcare infrastructure are also driving the demand for muscle relaxants in the region. Apart from this, the Asian region is predicted to emerge as the fastest-growing muscle relaxant drugs market in the coming years, which is due to the rising prevalence of chronic diseases, increasing number of surgeries, and surging geriatric population.
Hence, the demand for muscle relaxant drugs is also growing due to the rising geriatric population and increasing incidence of skin diseases around the globe.